The Affiliated Hospital Of Xuzhou Medical University

This study tests a combination of five drugs (tislelizumab, cyclophosphamide, mitoxantrone liposomes, chidamide, and prednisone) in 40 adults newly diagnosed with angioimmunoblastic T-cell lymphoma (AITL), a rare and aggressive blood cancer. The goal is to see if this mix improve…

This early-phase trial is testing whether adding an experimental drug (AT1019) to standard radiation and immunotherapy is safe for people with advanced solid tumors. About 12 adults whose cancer has not gotten worse on immunotherapy will receive the combination. The main goal is …

This early study tests a new drug called HN2302 in 6 adults with refractory myasthenia gravis, a condition where the immune system attacks the connection between nerves and muscles, causing weakness. The main goal is to see if the drug is safe and tolerable. Researchers will also…

This study looks at how certain genes influence the effectiveness of common diabetes drugs like exenatide and liraglutide in people with type 2 diabetes. Researchers will analyze blood samples and health data from 300 participants to find genetic markers that predict better blood…